MYLAN 199 Pill: white, round, 8mm
The pill with imprint MYLAN 199 (White, Round, 8mm) has been identified as Clonidine Hydrochloride 0.3 mg and is used for ADHD, High Blood Pressure, and Pain. It belongs to the drug class antiadrenergic agents, centrally acting and is not a controlled substance.
Images for MYLAN 199
Clonidine Hydrochloride
- Imprint
- MYLAN 199
- Strength
- 0.3 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
ammonium chloride,
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0199 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0301 (Discontinued) | UDL Laboratories Inc. |
| 49999-0438 | Lake Erie Medical and Surgical Supply (repackager) |
| 63874-1014 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
See also:
More about clonidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (779)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
Patient resources
- Clonidine drug information
- Clonidine injection
- Clonidine transdermal
- Clonidine (Epidural) (Advanced Reading)
Other brands
Catapres, Kapvay, Onyda XR, Catapres-TTS, ... +2 more
Professional resources
- CloNIDine, cloNIDine Hydrochloride monograph
- Clonidine (FDA)
- Clonidine Extended Release Tablets (FDA)
- Clonidine Injection (FDA)
- Clonidine Patch (FDA)
- Clonidine Tablets (FDA)
Other brands
Catapres, Kapvay, Onyda XR, Catapres-TTS, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.